740.0000 -4.60 (-0.62%)
NSE Sep 22, 2025 15:10 PM
Volume: 211.3K
 

Axis Direct
we maintain a BUY rating with a target price of Rs 615/share with a valuation of 21x EV/EBITDA for Sep 27E. The TP implies an upside potential of 10% from the CMP.
Number of FII/FPI investors increased from 226 to 257 in Jun 2025 qtr.
More from Krishna Institute of Medical Sciences Ltd.
Recommended